Medical/Pharmaceuticals

Seegene develops PCR test to detect monkeypox virus

* Assay targets monkeypox virus and can deliver results in 90 minutes * Company swiftly rolls out product using its automated assay development system * "Seegene will strive to make accurate tests for emerging viruses to help prevent future pandemics" SEOUL, South Korea, June 28, 2022 /PRN...

2022-06-28 19:00 3565

Ascletis Announced First Subject Dosed in the Phase II Clinical Trial of ASC22 (Envafolimab) for Immune Restoration/ Functional Cure of HIV-1 Infection

-- The Phase II clinical study in China is currently expected to be completed in early 2023 with an expected enrollment of 30 subjects HANGZHOU, China and SHAOXING, China, June 28, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the first subject has been ...

2022-06-28 18:11 3788

DeepGI - A Thai Innovation for the Precision in Colorectal Polyp Detection

Chula Engineering and Chula Medicine co-invent an innovative device for a rapid and accurate gastrointestinal cancer detection hoping to foster preventive medicine and reduce the number of cancer patients. BANGKOK, June 28, 2022 /PRNewswire/ -- Many types of cancers, especially gastric and color...

2022-06-28 13:02 4093

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program

CAMBRIDGE, Mass., and PERTH, Australia, June 28, 2022 /PRNewswire/ -- Summary The Institute of Functional Neuroscience, a world leading treatment and rehabilitation centre utilising the latest technologies in neuroplasticity research, and MetaCell, an innovative life science software company spe...

2022-06-28 09:05 3230

Cargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development

SINGAPORE, BOSTON and SHANGHAI, June 28, 2022 /PRNewswire/ -- Cargene Biopharma Inc. ("Cargene", the "Company"), a biopharmaceutical company developing oligonucleotide therapeutics for liver and ophthalmic disorders, is excited to welcomeKathy He, a seasoned biopharmaceutical industry executive, ...

2022-06-28 09:00 8835

Transcenta was Selected to Present the Preclinical Data of TST004 at the 2022 ISN Frontiers Meetings of Complement Related Kidney Diseases

SUZHOU, China, June 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it was selected ...

2022-06-28 08:00 3285

BGI Group Continues To Lead In Life Sciences 22 Years After The Human Genome Project

SHENZHEN, China, June 27, 2022 /PRNewswire/ -- BGI Group continues to lead in life sciences, making breakthroughs from single cell technology to spatiotemporal genomics, 22 years after participating in the Human Genome Project (HGP). BGI was formed to be a part of the HGP, contributing to the se...

2022-06-27 16:20 2735

JOYSBIO offers SARS-COV-2 Antigen Rapid Test that detects Omicron subvariants BA.4 and BA.5

TIANJIN, China, June 27, 2022 /PRNewswire/ -- As the SARS-COV-2 Omicron subvariants BA.4 and BA.5 make their way across the EU and the US, Joysbio is able to give people the power to administer a rapid test for themselves at home. The Joysbio Coronavirus Antigen Rapid Test Kit can effectively det...

2022-06-27 15:30 4413

Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines

TAIZHOU, China, June 27, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. is pleased to announce that, the Group has recently received the clinical trial approval (the"Clinical Trial Approval") for its R520A, a mRNA COVID-19 vaccine ("R520A"), from the Food and Drug Administration ofthe P...

2022-06-27 14:47 4846

Abcam: Appointment of Vice President of Investor Relations

CAMBRIDGE, England, June 27, 2022 /PRNewswire/ -- Abcam  plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment ofTommy Thomas as Vice President of Investor Relations...

2022-06-27 14:00 4144

Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma

-    Selinexor is an oral small molecule XPO1 inhibitor; tislelizumab is an anti-PD-1 checkpoint inhibitor SHANGHAI and HONG KONG, June 27, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedi...

2022-06-27 08:30 3780

Ascletis' Subcutaneous PD-L1 Antibody ASC22 Demonstrated Potential of Functional Cure of Chronic Hepatitis B as 42.9% of Patients with Baseline HBsAg≤100 IU/mL Obtained Sustained HBsAg Loss

--Ascletis presented Phase IIb clinical trial results of subcutaneous PD-L1 antibody ASC22 for functional cure of CHB at oral session of EASL ILC 2022 on June 25, 2022, Beijing Time --The Phase IIb clinical trial results further demonstrated the potential of ASC22+NAs treatment as a functional cu...

2022-06-27 08:11 4208

Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, June 27, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and o...

2022-06-27 08:00 5152

EAN Congress 2022: COVID-19 positive patients at higher risk of developing neurodegenerative disorders, new study shows

COVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown. VIENNA, June 25, 2022 /PRNewswire/ -- The study, which...

2022-06-25 06:01 6975

WhaleTeq: Widespread as AEDs Are, Have These Life-Saving Machines Really Come in Handy?

TAIPEI, June 24, 2022 /PRNewswire/ -- Unlike most products, AEDs sit idle most of the time. However, a life-or-death situation follows when it's being used. The consequences can be tragic if an AED isn't properly maintained. WhaleTeq, a professional medical device test solution provider proposed ...

2022-06-24 12:00 4640

Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17

* Upon authorization, Nuvaxovid™ would be the first protein-based option for adolescents aged 12 through 17 inEurope * Nuvaxovid™ demonstrated 80% efficacy and was generally well-tolerated in adolescents GAITHERSBURG, Md., June 24, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechn...

2022-06-24 03:24 5537

Use of BioMAP Platform to Assess Nutraceuticals Published in BioMed Central

ST. CHARLES, Mo., June 24, 2022 /PRNewswire/ -- Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announces a client publication advancing cognitive health research through use of the company's BioMAP...

2022-06-24 01:00 2985

MGI Wins Company Innovation of the Year at 2022 Globee® Awards for Advanced COVID-19 Response Efforts

SHENZHEN, China, June 24, 2022 /PRNewswire/ -- MGI, a company committed to being a world-leading life science innovator, has been awarded a Silver Globee® in the 14th Annual 2022 Golden Bridge Business and Innovation Awards® for its innovative COVID-19 pandemic control and response efforts worldw...

2022-06-24 00:17 3886

Berry Oncology launches HIFI Pan-Cancer Screening, a multi-cancer early screening product for detecting six high-risk cancers at one time

BEIJING, June 23, 2022 /PRNewswire/ -- On June 23, Berry Oncology, a global leading company specialized in genomic testing and early cancer screening, announced the launch of its innovative one-time precision product HIFI Pan-Cancer Screening, which is an early multi-cancer screening product ...

2022-06-23 22:39 3710

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

* Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) * Merck now one of industry's largest manufacturers of these components globally * Builds on company's 30 years' CDMO experience with multi-step, complex, and highly potent compounds DARMSTAD...

2022-06-23 21:00 5541
1 ... 317318319320321322323 ... 381